M
Michael L. Chikindas
Researcher at Rutgers University
Publications - 155
Citations - 9015
Michael L. Chikindas is an academic researcher from Rutgers University. The author has contributed to research in topics: Bacteriocin & Nisin. The author has an hindex of 42, co-authored 144 publications receiving 7687 citations. Previous affiliations of Michael L. Chikindas include Janssen Pharmaceutica & Southern Federal University.
Papers
More filters
Journal ArticleDOI
Bacteriocins: Safe, natural antimicrobials for food preservation
TL;DR: Toxicity data exist for only a few bacteriocins, but research and their long-time intentional use strongly suggest that bacteriOCins can be safely used.
Journal ArticleDOI
Listeria: A foodborne pathogen that knows how to survive
TL;DR: This review focuses on the key issues such as survival of the pathogen in adverse environments, and the important adaptation and survival mechanisms such as biofilm formation, quorum sensing and antimicrobial resistance.
Journal ArticleDOI
Functions and emerging applications of bacteriocins.
TL;DR: Some bacteriocins are found to regulate quorum sensing which suggests novel applications for this group of substances, which paves the way to even more fascinating applications such as novel carrier molecules (delivery systems) and the treatment of cancer.
Journal ArticleDOI
Pediocin PA-1, a Bacteriocin from Pediococcus acidilactici PAC1.0, Forms Hydrophilic Pores in the Cytoplasmic Membrane of Target Cells
Michael L. Chikindas,Maria J. García-Garcerá,Arnold J. M. Driessen,Aat M. Ledeboer,Jon Nissen-Meyer,Ingolf F. Nes,T Abee,Wilhelmus Konings,Gerhardus Venema +8 more
TL;DR: The data suggest that pediocin PA-1 functions in a voltage-independent manner but requires a specific protein in the target membrane, while it is less effective with membranes derived from immune cells.
Journal ArticleDOI
Isolation of the Bacillus subtilis antimicrobial peptide subtilosin from the dairy product-derived Bacillus amyloliquefaciens.
TL;DR: An antimicrobial protein (bacteriocin) isolated from the dairy product‐derived Bacillus amyloliquefaciens is isolated and characterized to purify and characterize an antimicrobialprotein.